0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Clinical and Biological Basis of Lung Cancer Prevention (Paperback, Softcover reprint of the original 1st ed. 1998) Loot Price: R1,485
Discovery Miles 14 850
Clinical and Biological Basis of Lung Cancer Prevention (Paperback, Softcover reprint of the original 1st ed. 1998): Yves...

Clinical and Biological Basis of Lung Cancer Prevention (Paperback, Softcover reprint of the original 1st ed. 1998)

Yves Martinet, F. R. Hirsch, J. Mulshine, J.M. Vignaud

Series: Respiratory Pharmacology and Pharmacotherapy

 (sign in to rate)
Loot Price R1,485 Discovery Miles 14 850 | Repayment Terms: R139 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Lung cancer is a disease with pandemic public health implications as it is now the leading cause of cancer mortality throughout the world. This book results from two recent International Association for the Study of Lung Cancer (IASLC) Workshops on lung cancer prevention. It strikes a balance between considering public health approaches to tobacco control and population-based screening, advances in clinical evaluation of chemoprevention approaches, and the biology of lung carcinogenesis. Indeed, while the science of smoking cessation is evolving as new pharmacological tools are moving into clinical evaluation, the current impact of molecular diagnostics is profound. The rapidly-evolving diagnostic technologies are revolutionizing basic scientific investigation of cancer, and this trend is expected to soon spill over into the clinical practice of medicine. The evolution of economical diagnostic platforms to allow for direct bronchial epithelial evaluation in high-risk populations promises to improve the diagnostic lead-time for this disease. The hope is that enough progress will occur to permit lung cancer detection in advance of clinical cancer so that the disease can be addressed early on, while it is still confined to the site of origin. Chemoprevention, which is designed to intervene in the early phase of carcinogenesis prior to any subjective clinical manifestation of a cancer, is also generating greater research interest. Moreover, the benefit of aerosolized administration of chemoprevention agents over conventional oral administration has strong appeal and may result in the reduction of the incidence of cancer when combined with new diagnostic technologies.

General

Imprint: Birkhauser Verlag AG
Country of origin: Switzerland
Series: Respiratory Pharmacology and Pharmacotherapy
Release date: November 2012
First published: 1998
Editors: Yves Martinet • F. R. Hirsch • J. Mulshine • J.M. Vignaud
Dimensions: 235 x 155 x 19mm (L x W x T)
Format: Paperback
Pages: 326
Edition: Softcover reprint of the original 1st ed. 1998
ISBN-13: 978-3-03-489829-4
Categories: Books > Medicine > Clinical & internal medicine > Respiratory medicine
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 3-03-489829-0
Barcode: 9783034898294

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners